About us
The idea of creating a network for the Nordic biosafety community was initiated at a symposium on Biosafety at the Swedish Institute for Infectious Disease Control (SMI) (present Folkhälsomyndigheten) in September 2004. One year later, in October 2005, the very first meeting of the Nordic Biosafety Network was held in Södertälje, Sweden, hosted by AstraZeneca.
Today, the Nordic Biosafety Network convenes annually for 1-2 days in any of the Nordic countries, organised by a local committee. Meeting participation is always free of charge, while participants finance travel expenses accommodation and meals.
Topics related to applied laboratory biological biosafety and biosecurity are presented and discussed and every meeting has its own unique features depending on the specialised expertise and interest of the local organisers.
The Nordic biosafety Network is an expanding community with members from national authorities and institutes, public health, academia and industry.
Partners and members
Sweden
AstraZeneca
Gentekniknämnden
Högskolan Kristianstad
Karolinska Institutet (KI)
Karolinska universitetssjukhuset
Myndigheten för samhällsskydd och beredskap
Livsmedelsverket
Lunds universitet
Medivir AB
Novozymes Biopharma AB
Folkhälsomyndigheten
Statens veterinärmedicinska anstalt (SVA)
Stockholm International Peace Research Institute (SIPRI)
Sveriges lantbruksuniversitet
Södertörns högskola
Totalförsvarets forskningsinstitut (FOI)
Umeå universitet
Universitetssjukhuset, Linköping
Valneva
Växjö universitet
Örebro universitet
Norway
Norwegian Institute of Public Health, Folkehelseinstituttet
Det Norske Veritas (DNV)
Norges veterinærhøgskole
Ullevål universitetssykehus
Veterinærinstituttet
Denmark
H. Lundbeck A/S
Københavns Universitet
NOVO Nordisk A/S
Novozymes A/S
Statens Serum Institut (SSI)
The Centre for Biosecurity and Biopreparedness (CBB)
Finland
Finnish Food Safety Authority (Evira)
Helsinki University Hospital (HUS)
National Institute for Health and Welfare (THL)